PTPIPetros Pharmaceuticals, Inc.vs its industry peers
A metric-by-metric comparison of Petros Pharmaceuticals, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PTPI본 종목 | $3M#8 | 0.1x#5 | 3.8x#13 | 0.5x#1 | -12.2%#3 | 113.4%#1 | -90.8%#1 | 273.0%#1 | — | — | -50.7%#2 | — |
| HCWB | $4M#1 | 0.1x#6 | 0.5x#5 | 69.4x#12 | -97.9%#11 | 73.5%#3 | -24270.7%#11 | -107.2%#5 | -99.4%#1 | 3#3 | -93.1%#4 | — |
| BIVIW | $4M#2 | — | 0.4x#4 | — | — | -25.8%#14 | — | -214.9%#8 | -1671.2%#3 | — | -7.7%#1 | — |
| SILO | $3M#3 | 0.7x#8 | 0.7x#8 | 46.7x#10 | 0.0%#2 | 3.8%#11 | -5937.0%#9 | -86.5%#2 | — | — | — | — |
| APVO | $3M#4 | 0.0x#2 | 0.5x#6 | 1.0x#2 | -74.7%#10 | -7.6%#12 | -845.0%#4 | -429.8%#10 | — | — | — | — |
| GOVX | $3M#5 | — | 1.7x#12 | 1.2x#3 | -37.1%#5 | 14.1%#7 | -869.3%#5 | -1219.1%#12 | — | — | -97.6%#5 | — |
| SXTP | $3M#6 | — | 1.2x#10 | 3.0x#5 | 65.5%#1 | 7.3%#8 | -771.6%#3 | -281.7%#9 | -163.8%#2 | 6#1 | — | — |
| GNPX | $3M#7 | 0.0x#3 | 0.2x#2 | — | — | 24.1%#5 | — | -109.7%#6 | — | — | -98.9%#6 | — |
| ONCO | $3M#9 | 0.0x#1 | 0.2x#1 | 3.1x#6 | -67.7%#7 | 76.1%#2 | -2190.0%#7 | -104.2%#4 | — | — | -99.6%#7 | — |
| ZVSA | $2M#10 | — | — | — | — | -165.1%#15 | — | — | — | — | — | — |
| MTNB | $2M#11 | — | 1.3x#11 | 2.2x#4 | -65.6%#6 | 57.3%#4 | -635.0%#2 | -574.7%#11 | — | — | — | — |
| BTAI | $2M#12 | — | — | 3.6x#7 | -71.7%#9 | -17.3%#13 | -7860.0%#10 | — | — | — | — | — |
| OGEN | $2M#13 | 0.5x#7 | 0.6x#7 | 61.1x#11 | -71.4%#8 | 6.9%#10 | -24865.2%#12 | -26814.1%#13 | — | — | -58.2%#3 | — |
| BFRGW | $2M#14 | — | 0.3x#3 | 17.8x#9 | — | 7.1%#9 | -5652.4%#8 | -93.0%#3 | -5287.3%#4 | — | — | — |
| NXTS | $2M#15 | 0.0x#4 | 1.0x#9 | 9.1x#8 | -20.2%#4 | 22.9%#6 | -2014.3%#6 | -210.2%#7 | — | 4#2 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-16.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice